248 related articles for article (PubMed ID: 23324964)
1. Ultraporous β-tricalcium phosphate alone or combined with bone marrow aspirate for benign cavitary lesions: comparison in a prospective randomized clinical trial.
Damron TA; Lisle J; Craig T; Wade M; Silbert W; Cohen H
J Bone Joint Surg Am; 2013 Jan; 95(2):158-66. PubMed ID: 23324964
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of ultraporous β-tricalcium phosphate (vitoss) as bone graft substitute for cavitary defects in benign and low-grade malignant bone tumors.
Van Hoff C; Samora JB; Griesser MJ; Crist MK; Scharschmidt TJ; Mayerson JL
Am J Orthop (Belle Mead NJ); 2012 Jan; 41(1):20-3. PubMed ID: 22389890
[TBL] [Abstract][Full Text] [Related]
3. Ultraporous beta-tricalcium phosphate is well incorporated in small cavitary defects.
Anker CJ; Holdridge SP; Baird B; Cohen H; Damron TA
Clin Orthop Relat Res; 2005 May; (434):251-7. PubMed ID: 15864061
[TBL] [Abstract][Full Text] [Related]
4. The outcome of composite bone graft substitute used to treat cavitary bone defects.
Siegel HJ; Baird RC; Hall J; Lopez-Ben R; Lander PH
Orthopedics; 2008 Aug; 31(8):754. PubMed ID: 19292421
[TBL] [Abstract][Full Text] [Related]
5. Comparative performance of three ceramic bone graft substitutes.
Hing KA; Wilson LF; Buckland T
Spine J; 2007; 7(4):475-90. PubMed ID: 17630146
[TBL] [Abstract][Full Text] [Related]
6. Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: a prospective, randomized study with 3-year follow-up.
Dai LY; Jiang LS
Spine (Phila Pa 1976); 2008 May; 33(12):1299-304. PubMed ID: 18496340
[TBL] [Abstract][Full Text] [Related]
7. Unexpected radiographic lucency following grafting of bone defects with calcium sulfate/tricalcium phosphate bone substitute.
Auston DA; Feibert M; Craig T; Damron TA
Skeletal Radiol; 2015 Oct; 44(10):1453-9. PubMed ID: 26081807
[TBL] [Abstract][Full Text] [Related]
8. A level-1 pilot study to evaluate of ultraporous beta-tricalcium phosphate as a graft extender in the posterior correction of adolescent idiopathic scoliosis.
Lerner T; Bullmann V; Schulte TL; Schneider M; Liljenqvist U
Eur Spine J; 2009 Feb; 18(2):170-9. PubMed ID: 19082847
[TBL] [Abstract][Full Text] [Related]
9. [Tricalcium phosphate mixed with autologous bone marrow in the treatment of benign cystic bone lesions in children].
Ondruš S; Straka M; Bajerová J
Acta Chir Orthop Traumatol Cech; 2011; 78(6):544-50. PubMed ID: 22217408
[TBL] [Abstract][Full Text] [Related]
10. Basic research and clinical application of beta-tricalcium phosphate (β-TCP).
Tanaka T; Komaki H; Chazono M; Kitasato S; Kakuta A; Akiyama S; Marumo K
Morphologie; 2017 Sep; 101(334):164-172. PubMed ID: 28462796
[TBL] [Abstract][Full Text] [Related]
11. Bone healing and graft resorption of autograft, anorganic bovine bone and beta-tricalcium phosphate. A histologic and histomorphometric study in the mandibles of minipigs.
Jensen SS; Broggini N; Hjørting-Hansen E; Schenk R; Buser D
Clin Oral Implants Res; 2006 Jun; 17(3):237-43. PubMed ID: 16672017
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial.
Nevins M; Giannobile WV; McGuire MK; Kao RT; Mellonig JT; Hinrichs JE; McAllister BS; Murphy KS; McClain PK; Nevins ML; Paquette DW; Han TJ; Reddy MS; Lavin PT; Genco RJ; Lynch SE
J Periodontol; 2005 Dec; 76(12):2205-15. PubMed ID: 16332231
[TBL] [Abstract][Full Text] [Related]
13. rhPDGF-BB promotes healing of periodontal defects: 24-month clinical and radiographic observations.
McGuire MK; Kao RT; Nevins M; Lynch SE
Int J Periodontics Restorative Dent; 2006 Jun; 26(3):223-31. PubMed ID: 16836164
[TBL] [Abstract][Full Text] [Related]
14. Effect of platelet-rich plasma on the healing of intrabony defects treated with Beta tricalcium phosphate and expanded polytetrafluoroethylene membranes.
Döri F; Huszár T; Nikolidakis D; Tihanyi D; Horváth A; Arweiler NB; Gera I; Sculean A
J Periodontol; 2008 Apr; 79(4):660-9. PubMed ID: 18380559
[TBL] [Abstract][Full Text] [Related]
15. Bone regeneration using beta-tricalcium phosphate in a calcium sulfate matrix.
Podaropoulos L; Veis AA; Papadimitriou S; Alexandridis C; Kalyvas D
J Oral Implantol; 2009; 35(1):28-36. PubMed ID: 19288885
[TBL] [Abstract][Full Text] [Related]
16. [Clinical results and the mechanism of bone healing for the repair of bone defects due to tumor resection with novel interporous TCP].
Sang H; Wang Z; Guo Z; Wang L; Li J; Meng G; Li X; Lu J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):463-7. PubMed ID: 18575450
[TBL] [Abstract][Full Text] [Related]
17. Minimally invasive transcrestal sinus floor elevation with deproteinized bovine bone or β-tricalcium phosphate: a multicenter, double-blind, randomized, controlled clinical trial.
Trombelli L; Franceschetti G; Stacchi C; Minenna L; Riccardi O; Di Raimondo R; Rizzi A; Farina R
J Clin Periodontol; 2014 Mar; 41(3):311-9. PubMed ID: 24325663
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive use of ultraporous beta-tricalcium phosphate bone void filler in spinal arthrodesis.
Meadows GR
Orthopedics; 2002 May; 25(5 Suppl):s579-84. PubMed ID: 12038845
[TBL] [Abstract][Full Text] [Related]
19. Does bone marrow affect the radiological outcome when added to biphasic ceramic graft in treatment of benign bone lesions?
El-Adl G; Ali AM
Eur J Orthop Surg Traumatol; 2013 Jan; 23(1):13-20. PubMed ID: 23412403
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcome of Beta-Tricalcium Phosphate Use for Bone Defects after Operative Treatment of Benign Tumors.
Chung H; Kim S; Chung SH
Clin Orthop Surg; 2019 Jun; 11(2):233-236. PubMed ID: 31156777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
